Australia Veterinary Healthcare Market by Products (Therapeutics [Vaccines, Anti-infectives, Medical Feed Additives, Parasiticides, and Others]and Diagnostics [Molecular Diagnostics, Diagnostic Imaging, Immunodiagnostic Tests, Clinical Chemistry, and Other]), Animal Types (Dogs & Cats, Horses, Ruminants, Swine, Poultry, and Other), and Country- Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

When compared to the other major Australian livestock businesses, the meat chicken industry, or broiler industry, has a comparatively short history. In Australia, there are presently around 800 commercial meat chicken growers. Gradually rising poultry and livestock business leads to growing demand for feed additives in the country.

Animal Health Australia (AHA) collaborates with its members to keep Australia free of exotic animal illness, promote animal health and market access, and strengthen the country's animal health system's resilience and integrity.

Surveillance is critical to achieving these objectives because it allows for early identification of disease outbreaks and the release of credible national reports on livestock and their products' health. Policy development, decision-making, and trade are all aided by credible reporting. Acceptance of illness absence evidence is being replaced by a demand for proof of disease absence.

In Australia, officials from the federal government, state and territory governments, and municipal governments work together to provide veterinary services. These three levels of government work together to serve Australia's values and interests.

The Office of the Chief Veterinary Officer (OCVO) and the Animal Health Policy section of the Department of Agriculture and Water Resources are in charge of establishing policy and giving scientific advice on animal health issues, including veterinary elements of zoonotic disease control (diseases that may be transferred from animals to people), counterterrorism (where biological weapons could be employed for terrorist operations), and veterinary public health monitoring and surveillance.

On May 30, 2020, Australian Centre for Disease Preparedness verified the dogs were afflicted with Ehrlichia canis (E. canis), a bacteria spread by ticks that causes canine ehrlichiosis, a nationally notifiable condition.

A novel technology for testing ticks led to the discovery of E. canis in ticks in northern South Africa, before any dogs in the state had shown signs of the disease.

The Australian and state/territory governments, along with maritime industry and marine scientists, are implementing Australia's National System for the Prevention and Management of Marine Pest Incursions to preserve our marine environment and industries (the National System).
The National System attempts to avoid the arrival of new marine pests, direct actions when they do, and reduce the spread and effect of pests that have already established themselves in Australia.

Market Trends, Drivers, Restraints, and Opportunities

• Increasing farm owners’ conscious for pet health’s is projected to boost the market during the forecast period.
• Rising risk of disease spread by animal’s is anticipated to drive the market expansion in the coming years.
• Growing demand for animal-based products are expected to propel the market.
• Increasing animal adoption and animal care centers in the country are estimated to spur the market.
• Rapid growth of the healthcare industry is main factors boosting the market growth in the coming years.
• Rising number of diseases in animals is projected to surge the product demand.
• High R&D cost on development of new technology act as a major challenge to hinder the market growth.
• Development innovation and sophisticated technology for treatment and diagnosis are expected to create significant opportunities for the market players.

Scope of the Report

The report on the Australia veterinary healthcare market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Australia Veterinary Healthcare Market Segment Insights

The vaccines segment is projected to account for a major market share

Based on products, the Australia veterinary healthcare market is divided into therapeutics and diagnostics. The therapeutics segment is further segmented to vaccines, anti-infectives, medical feed additives, parasiticides, and others. The vaccines expected to represent a key share of the market during the forecast period owing to improve the immunity of animals against virus and their variants.

The poultry segment is expected to grow at a robust pace

On the types, the Australia veterinary healthcare market is segmented into dogs & cats, horses, ruminants, swine, poultry, and other. The poultry segment is expected to hold a key share of the market in the coming years owing to increasing consumption of chicken meat in the country also rising instances of natural infection of influenza Type A viruses in birds.

Segments

• Therapeutics

• Vaccines
• Anti-infectives
• Medical Feed Additives
• Parasiticides
• Others

• Diagnostics

• Molecular Diagnostics
• Diagnostic Imaging
• Immunodiagnostic Tests
• Clinical Chemistry
• Other

• Dog & Cat
• Horses
• Ruminants
• Swine
• Poultry
• Others

• United Kingdom

• Zoetis Inc
• Elanco
• Vetoquinol SA
• Merck Co. Inc.
• Boehringer Ingelheim

Competitive Landscape

Key players competing in the Australia veterinary healthcare market include Zoetis Inc; Elanco; Vetoquinol SA; Merck Co. Inc.; Boehringer Ingelheim.

Some of these players are coming up with several market strategies including mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase/enhance their market shares.